View in EDS

A prospective phase II study of adjuvant postoperative radiation therapy following nodal surgery in malignant melanoma–Trans Tasman Radiation Oncology Group (TROG) Study 96.06

Saved in:
Bibliographic Details
Title: A prospective phase II study of adjuvant postoperative radiation therapy following nodal surgery in malignant melanoma–Trans Tasman Radiation Oncology Group (TROG) Study 96.06
Authors: Burmeister, Bryan H.1 Bryan_Burmeister@health.qld.gov.au, Mark Smithers, B.1, Burmeister, Elizabeth2, Baumann, Kathryn3, Davis, Sidney4, Krawitz, Hedley5, Johnson, Carol6, Spry, Nigel7
Source: Radiotherapy & Oncology. Nov2006, Vol. 81 Issue 2, p136-142. 7p.
Subjects: Melanoma, Radiotherapy, Neuroendocrine tumors, Lymph nodes
Abstract: Abstract: Background: The role of adjuvant postoperative therapy after resection of localised malignant melanoma involving regional lymph nodes remains controversial. There are no randomised trials that confirm that postoperative radiation conveys a benefit in terms of regional control or survival. Methods: Two hundred and thirty-four patients with melanoma involving lymph nodes were registered on a prospective study to evaluate the effect of postoperative radiation therapy. The regimen consisted of 48Gy in 20 fractions to the nodal basin using recommended treatment guidelines for each of the major node sites. The primary endpoints were regional in-field relapse and late toxicity. Secondary endpoints were adjacent relapse, distant relapse, overall survival, progression-free survival and time to in-field progression. Results: Adjuvant radiation therapy was well tolerated by all of the patients. As the first site of relapse, regional in-field relapses occurred in 16/234 patients (6.8%). The overall survival was 36% at 5 years. The progression-free survival and regional control rates were 27% and 91%, respectively, at 5 years. Patients with more than 2 nodes involved had a significantly worse outcome in terms of distant relapse, overall and progression-free survival. Conclusion: We believe that adjuvant radiation therapy following nodal surgery could offer a possible benefit in terms of regional control. These results require confirmation in a randomised trial. [Copyright &y& Elsevier]
Copyright of Radiotherapy & Oncology is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Engineering Source
FullText Text:
  Availability: 0
Header DbId: egs
DbLabel: Engineering Source
An: 23048154
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A prospective phase II study of adjuvant postoperative radiation therapy following nodal surgery in malignant melanoma–Trans Tasman Radiation Oncology Group (TROG) Study 96.06
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Burmeister%2C+Bryan+H%2E%22">Burmeister, Bryan H.</searchLink><relatesTo>1</relatesTo><i> Bryan_Burmeister@health.qld.gov.au</i><br /><searchLink fieldCode="AR" term="%22Mark+Smithers%2C+B%2E%22">Mark Smithers, B.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Burmeister%2C+Elizabeth%22">Burmeister, Elizabeth</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Baumann%2C+Kathryn%22">Baumann, Kathryn</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Davis%2C+Sidney%22">Davis, Sidney</searchLink><relatesTo>4</relatesTo><br /><searchLink fieldCode="AR" term="%22Krawitz%2C+Hedley%22">Krawitz, Hedley</searchLink><relatesTo>5</relatesTo><br /><searchLink fieldCode="AR" term="%22Johnson%2C+Carol%22">Johnson, Carol</searchLink><relatesTo>6</relatesTo><br /><searchLink fieldCode="AR" term="%22Spry%2C+Nigel%22">Spry, Nigel</searchLink><relatesTo>7</relatesTo>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Radiotherapy+%26+Oncology%22">Radiotherapy & Oncology</searchLink>. Nov2006, Vol. 81 Issue 2, p136-142. 7p.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Melanoma%22">Melanoma</searchLink><br /><searchLink fieldCode="DE" term="%22Radiotherapy%22">Radiotherapy</searchLink><br /><searchLink fieldCode="DE" term="%22Neuroendocrine+tumors%22">Neuroendocrine tumors</searchLink><br /><searchLink fieldCode="DE" term="%22Lymph+nodes%22">Lymph nodes</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: Abstract: Background: The role of adjuvant postoperative therapy after resection of localised malignant melanoma involving regional lymph nodes remains controversial. There are no randomised trials that confirm that postoperative radiation conveys a benefit in terms of regional control or survival. Methods: Two hundred and thirty-four patients with melanoma involving lymph nodes were registered on a prospective study to evaluate the effect of postoperative radiation therapy. The regimen consisted of 48Gy in 20 fractions to the nodal basin using recommended treatment guidelines for each of the major node sites. The primary endpoints were regional in-field relapse and late toxicity. Secondary endpoints were adjacent relapse, distant relapse, overall survival, progression-free survival and time to in-field progression. Results: Adjuvant radiation therapy was well tolerated by all of the patients. As the first site of relapse, regional in-field relapses occurred in 16/234 patients (6.8%). The overall survival was 36% at 5 years. The progression-free survival and regional control rates were 27% and 91%, respectively, at 5 years. Patients with more than 2 nodes involved had a significantly worse outcome in terms of distant relapse, overall and progression-free survival. Conclusion: We believe that adjuvant radiation therapy following nodal surgery could offer a possible benefit in terms of regional control. These results require confirmation in a randomised trial. [Copyright &y& Elsevier]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of Radiotherapy & Oncology is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=egs&AN=23048154
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.radonc.2006.10.001
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 7
        StartPage: 136
    Subjects:
      – SubjectFull: Melanoma
        Type: general
      – SubjectFull: Radiotherapy
        Type: general
      – SubjectFull: Neuroendocrine tumors
        Type: general
      – SubjectFull: Lymph nodes
        Type: general
    Titles:
      – TitleFull: A prospective phase II study of adjuvant postoperative radiation therapy following nodal surgery in malignant melanoma–Trans Tasman Radiation Oncology Group (TROG) Study 96.06
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Burmeister, Bryan H.
      – PersonEntity:
          Name:
            NameFull: Mark Smithers, B.
      – PersonEntity:
          Name:
            NameFull: Burmeister, Elizabeth
      – PersonEntity:
          Name:
            NameFull: Baumann, Kathryn
      – PersonEntity:
          Name:
            NameFull: Davis, Sidney
      – PersonEntity:
          Name:
            NameFull: Krawitz, Hedley
      – PersonEntity:
          Name:
            NameFull: Johnson, Carol
      – PersonEntity:
          Name:
            NameFull: Spry, Nigel
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: Nov2006
              Type: published
              Y: 2006
          Identifiers:
            – Type: issn-print
              Value: 01678140
          Numbering:
            – Type: volume
              Value: 81
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Radiotherapy & Oncology
              Type: main
ResultId 1